Costco on Thursday reported another sturdy — if mixed — quarter, demonstrating that its focus on keeping prices low continues to bring more shoppers to its stores at an uncertain time for the U.S. economy. Total revenue in its second quarter of fiscal year 2025 rose 9% year over...
The bulls on Wall Street emerged victorious Friday but not for the week. Investors shook off a midday, end-of-the-week sell-off on geopolitical concerns sparked by President Donald Trump's Oval Office spat with Ukraine President Volodymyr Zelenskyy . Still, the advance Friday was not enough for the S & P...
Salesforce shares fell in extended trading Wednesday on mixed quarterly results and weak guidance. However, the enterprise software giant's AI business is picking up steam, which should propel the stock higher over time. Sales in the fiscal 2025 fourth quarter rose 8% on an annual basis to $9.99 billion,...
Shoppers never know exactly what they will find at a T.J. Maxx, Marshalls, or HomeGoods. Investors, on the other hand, are finding earnings from their parent company rather predictable. TJX Companies on Wednesday delivered a better-than-expected quarter but light outlook. The market was hardly concerned, sending shares up 3%,...
Home Depot on Tuesday reported better-than-expected fourth-quarter results, but high interest rates continue to cloud its outlook for the year. Net sales in the three months ended Feb. 2 rose 14.1% to $39.7 billion, topping estimates of $39.16 billion, according to LSEG. Earnings per share (EPS) increased 6.7% on...
Things continue to look up for GE Healthcare stock this year. Shares of the medical technology company jumped roughly 9% on Thursday after delivering solid fourth-quarter results and providing prudent 2025 guidance. While the Club stock left much to be desired in 2024, these numbers boosted shares that were...
Eli Lilly on Thursday reminded investors that the best growth story in large-cap pharmaceuticals has hardly grown stale, sending shares to their highest levels since October. Revenue in the three months ended Dec. 31 rose 45% year over year to $13.53 billion, in line with Wall Street expectations, according...
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer's faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts' estimates...
The rejuvenated Disney kept rolling Wednesday, delivering first-quarter results that beat expectations alongside reasons for optimism in the year ahead. Revenue in the three months ended Dec. 31 rose 5% on an annual basis to $24.69 billion, topping expectations of $24.62 billion, according to estimates compiled by LSEG. Adjusted...
BlackRock reported better-than-expected earnings Wednesday, lifting shares of the asset management giant higher as it embarks on a pivotal year of expansion into fast-growing markets. Revenue of $5.68 billion in the three months ended Dec. 31 exceeded expectations of $5.49 billion, according to LSEG. Adjusted earnings per share (EPS)...